11/22/2020, 4:16 AM (Source: TeleTrader)
more TeleTrader news

FDA approves Regeneron COVID-19 treatment

United States Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.'s coronavirus treatment for patients who are at high risk of developing a severe form of COVID-19. The emergency authorization allows the use of the antibody cocktail in persons over the age of 12, including those who are 65 years of age or older or who have certain chronic medical conditions.

The FDA pointed to trials which showed that the treatment was shown to "reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression within 28 days after treatment when compared to placebo." The body noted that it will continue to evaluate the safety and effectiveness of the therapy, which was given to US President Donald Trump when he was treated for COVID-19.

Breaking the News / DJ